Amgen v. Sanofi: The Supreme Court Takes up the Enablement Requirement in the Context of Therapeutic Monoclonal Antibodies

Authors

Christopher M. Holman, University of Missouri - Kansas City, School of LawFollow

Publication Date

12-7-2022

Document Type

Article

Publication Title

Biotechnology Law Report

Volume

41

Issue

6

Recommended Citation

Christopher M. Holman, Amgen v. Sanofi: The Supreme Court Takes up the Enablement Requirement in the Context of Therapeutic Monoclonal Antibodies, 41 Biotechnology Law Report 269 (2022).
Available at: https://irlaw.umkc.edu/faculty_works/759